pLV-EF1A-CD19.8H.8TM.BB.3z Citations (1)
Originally described in: CD276-CAR T cells and Dual-CAR T cells targeting CD276/FGFR4 promote rhabdomyosarcoma clearance in orthotopic mouse models.Timpanaro A, Piccand C, Dzhumashev D, Anton-Joseph S, Robbi A, Moser J, Rossler J, Bernasconi M J Exp Clin Cancer Res. 2023 Nov 4;42(1):293. doi: 10.1186/s13046-023-02838-3. PubMed Journal
Articles Citing pLV-EF1A-CD19.8H.8TM.BB.3z
| Articles |
|---|
| IL-21/IL-21R signaling renders acute myeloid leukemia stem cells more susceptible to cytarabine treatment and CAR T cell therapy. Rubino V, Huppi M, Hopner S, Tortola L, Schnuriger N, Legenne H, Taylor L, Voggensperger S, Keller I, Bruggman R, Kronig MN, Bacher U, Kopf M, Ochsenbein AF, Riether C. Cell Rep Med. 2024 Nov 19;5(11):101826. doi: 10.1016/j.xcrm.2024.101826. Epub 2024 Nov 12. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.